Clinical Trials
ELIAS Animal Health has developed a unique immunotherapy treatment protocol which may permit the dog’s immune system to attack its own cancer cells. ELIAS Cancer Immunotherapy (ECI®)—a vaccine-enhanced adoptive cell therapy—has demonstrated effectiveness in clinical trials in both canines and humans, while avoiding or minimizing the need for chemotherapy or radiation treatment.
“The T cell expansion is a huge component that, to my knowledge, none of the other autologous products are even trying to replicate.”
Zachary Wright, DVM, DACVIM (Oncology)
VCA Animal Diagnostic Clinic